| Literature DB >> 34925329 |
Ying Guo1, Xiaojie Huang2, Xintong Sun1, Yixi Yu1, Yan Wang1, Baojin Zhang1, Jie Cao1, Shuo Wen1, Yuchen Li1, Xin Wang1, Siyu Cai3, Wei Xia2, Feili Wei4, Junyi Duan2, Haozhi Dong5, Shan Guo4, Fengqiu Zhang6, Dongxiang Zheng1, Zheng Sun6.
Abstract
Salivary virome is important for oral ecosystem, but there are few reports on people living with HIV. We performed metagenomic sequencing to compare composition and functional genes of salivary virobiota between one HIV-negative and four HIV-positive groups in which participants were all men who have sex with men (MSM) with different immunosuppression statuses (five samples per group) to find the evidence that salivary virobiota plays a role in the pathogenesis of oral disease. Acute-stage subjects achieved a positive result of HIV RNA, but HIV antibody negative or indeterminate, whereas individuals with mild, moderate, and severe immunosuppression exhibited CD4+ T-lymphocyte counts of at least 500, 200-499, and less than 200 cells/μL or opportunistic infection, respectively. The results showed the composition of salivary virus genera in subjects with mild immunosuppression was the most similar to that in healthy people, followed by that in the acute stage; under severe immunosuppression, virus genera were suppressed and more similar to that under moderate immunosuppression. Furthermore, abnormally high abundance of Lymphocryptovirus was particularly obvious in MSM with HIV infection. Analysis of KEGG Pathway revealed that Caulobacter cell cycle, which affects cell duplication, became shorter in HIV-positive subjects. It is worth noting that in acute-stage participants, protein digestion and absorption related to the anti-HIV-1 activity of secretory leukocyte protease inhibitor was increased. Moreover, in the severely immunosuppressed subjects, glutathione metabolism, which is associated with the activation of lymphocytes, was enhanced. Nevertheless, the ecological dysbiosis in HIV-positive salivary virobiota possibly depended on the changes in blood viral load, and salivary dysfunction of MSM infected with HIV may be related to CD4 counts. Ribonucleoside diphosphate reductase subunit M1 in purine metabolism was negatively correlated, though weakly, to CD4 counts, which may be related to the promotion of HIV-1 DNA synthesis in peripheral blood lymphocytes. 7-Cyano-7-deazaguanine synthase in folate biosynthesis was weakly positively correlated with HIV viral load, suggesting that this compound was produced excessively to correct oral dysfunction for maintaining normal cell development. Despite the limited number of samples, the present study provided insight into the potential role of salivary virome in the oral function of HIV infected MSM.Entities:
Keywords: HIV; men who have sex with men; metabolism; metagenomic analyses; saliva; virome
Mesh:
Year: 2021 PMID: 34925329 PMCID: PMC8674211 DOI: 10.3389/fimmu.2021.759253
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Characteristics of participants in the untreated MSM with HIV infection and control groups.
| Group | HIV_0 | HIV_1 | HIV_2 | HIV_3 | HIV_neg | Chi- |
|
|---|---|---|---|---|---|---|---|
| (n = 5) | (n = 5) | (n = 5) | (n = 5) | (n = 5) | square value | ||
| Age, years | 31 | 34 | 42 | 29 | 29 | 3.4527 | 0.4851 |
| (25.50, 43.00) | (24.50, 39.50) | (30.50, 46.00) | (22.50, 39.00) | (24.50, 39.00) | |||
| Periodontal state, n (%) | |||||||
| Healthy periodontal state | 1 (20.00) | 2 (40.00) | 1 (20.00) | 1 (20.00) | 1 (20.00) | 0.808 | 0.9374 |
| Periodontitis | 4 (80.00) | 3 (60.00) | 4 (80.00) | 4 (80.00) | 4 (80.00) | ||
| Mucosal state, n (%) | |||||||
| Healthy mucosal state | 5 (100.00) | 5 (100.00) | 5 (100.00) | 3 (70.00) | 5 (100.00) | 7.208 | 0.1253 |
| Oral candidiasis | 0 (0.00) | 0 (0.00) | 0 (0.00) | 2 (30.00) | 0 (0.00) | ||
| CD4 count, cells/μL | 354.33 (327.515, 470.52) | 675.08 (604.52, 761.575) | 243.00 (219.765, 374.725) | 186.85 (63.44,234.04) | ND | 15.7543 | 0.0013 |
| BVL, log10 copies/ml | 4.28 | 3.83 | 5.17 | 4.34 | – | 5.1792 | 0.1591 |
| (3.93, 4.94) | (3.47, 4.67) | (4.60, 5.465) | (3.965, 5.40) |
BVL, blood viral load; ND, Not detected; HIV_0, HIV-positive stage 0 group, HIV_1, HIV-positive stage 1 group, HIV_2, HIV-positive stage 2 group, HIV_3, HIV-positive stage 3 group, HIV_neg, HIV-negative control group.
Characteristics of participants are summarized using median with upper and lower quartiles or percentages and compared using Chi-square tests.
Figure 1Venn diagram of the distribution of salivary viral genera in the five groups. Overlapping parts represent shared species, and non-overlapping parts represent unique species. The bar graph shows the total number of species in each group.
Figure 2Community composition analysis diagram. (A) Heatmap visualizing the abundance of all viruses in saliva samples at the genus level. The left and upper sides are the species cluster tree and the sample cluster tree, respectively; the right and lower sides are different taxon groups of the family. Color intensity represents species abundance. (B) Circos diagram visualizing the abundance of viruses in saliva samples at the family level.
Figure 3LEfSe bar charts of differences between the HIV-positive groups and HIV-negative controls. (A) Differences in salivary viral abundances; (B) Differences in the salivary viral functions at KEGG Pathway Level 3.
Figure 4Correlation heatmap showing the relationships between the KOs of salivary virome of the top 60 abundance and BVL or CD4 counts in the four HIV-positive groups. Colors represent different r values (Spearman correlation coefficient): red and blue indicate positive and negative correlations, respectively. *0.01
Significantly correlated KO genes and their functions in the four HIV-positive groups.
| KO | r value |
| KO description | KEGG_Pathway | KEGG_Pathway description | |
|---|---|---|---|---|---|---|
| CD4 | K02314 | 0.51429 | 0.02035 | Replicative DNA helicase [EC:3.6.4.12] | ko03030 | DNA replication |
| ko04112 | Cell cycle— | |||||
| K07496 | 0.54532 | 0.01289 | putative transposase | – | – | |
| K10807 | −0.51246 | 0.02087 | Ribonucleoside diphosphate reductase subunit M1 [EC:1.17.4.1] | ko00230 | Purine metabolism | |
| ko00240 | Pyrimidine metabolism | |||||
| ko00480 | Glutathione metabolism | |||||
| BVL | K06920 | 0.51502 | 0.02014 | 7-Cyano-7-deazaguanine synthase [EC:6.3.4.20] | ko00790 | Folate biosynthesis |
| K18950 | 0.53870 | 0.01426 | Ribonuclease H [EC:3.1.26.4] | – | – |
KO, KEGG Orthology; EC, Enzyme naming and numbering of Enzyme Commission of IUB; ko, pathway of KOs.
Figure 5Metabolism pathway and annotated enzyme of the correlated KO genes. (A) Purine metabolism and [EC:1.17.4.1]; (B) Pyrimidine metabolism and [EC:1.17.4.1]; (C) Folate biosynthesis and [EC:6.3.4.20].